Toggle navigation
Home
Search
Services
Blog
Contact
About
Design of Inhibitors for Complement Protein Factor D
Babu, Y Sudhakara
Biocryst Pharmaceuticals, Inc., Birmingham, AL, United States
Search 146 grants from Y Babu
Search grants from Biocryst Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A novel vaccine against vaginal Chlamydia trachomatis
Development of an H2O2-Inactivated Dengue Virus Vaccine
Roles of STAT proteins in tumor vaccine development
Polymorphisms of Neural NOS and the Asthma Phenotype
CAREER: Comparative Statics and Dynamic Models
Recently added grants:
Expanding the known coding genome: identifying biological function for novel tORFs
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
Corticospinal neuron dysfunction and degeneration in ALS: testing the role of corticomotor connectivity in motor neuron disease
Schwann Cell Regulation of Hematopoiesis
Genomic Biology of the Tandem Duplicator Phenotype in Mouse and Human Cancers
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AR041095-03
Application #
2080467
Study Section
Special Emphasis Panel (ZRG7-SSS-6 (06))
Project Start
1994-02-16
Project End
1996-02-15
Budget Start
1995-04-05
Budget End
1996-02-15
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Biocryst Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Birmingham
State
AL
Country
United States
Zip Code
Related projects
NIH 1995
R44 AR
Design of Inhibitors for Complement Protein Factor D
Babu, Y Sudhakara / Biocryst Pharmaceuticals, Inc.
NIH 1994
R44 AR
Design of Inhibitors for Complement Protein Factor D
Babu, Y Sudhakara / Biocryst Pharmaceuticals, Inc.
Comments
Be the first to comment on this grant